GHIGLIERI, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 2.266
AS - Asia 1.847
EU - Europa 599
SA - Sud America 264
AF - Africa 56
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 11
Totale 5.063
Nazione #
US - Stati Uniti d'America 2.071
SG - Singapore 539
CN - Cina 521
TR - Turchia 352
IT - Italia 259
BR - Brasile 212
VN - Vietnam 185
CA - Canada 169
DE - Germania 93
GB - Regno Unito 56
HK - Hong Kong 56
FR - Francia 52
IN - India 36
PK - Pakistan 36
IE - Irlanda 22
NL - Olanda 21
BD - Bangladesh 20
EU - Europa 20
MX - Messico 18
AR - Argentina 17
IL - Israele 17
RU - Federazione Russa 17
ZA - Sudafrica 17
PL - Polonia 13
JP - Giappone 12
CO - Colombia 11
IQ - Iraq 11
ES - Italia 10
ID - Indonesia 10
MA - Marocco 10
RO - Romania 10
EC - Ecuador 9
SE - Svezia 9
FI - Finlandia 8
UA - Ucraina 8
AU - Australia 7
SA - Arabia Saudita 7
CL - Cile 6
KE - Kenya 6
PH - Filippine 6
TW - Taiwan 6
TN - Tunisia 5
UZ - Uzbekistan 5
JO - Giordania 4
LT - Lituania 4
MY - Malesia 4
NZ - Nuova Zelanda 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
EG - Egitto 3
GR - Grecia 3
PE - Perù 3
PS - Palestinian Territory 3
RS - Serbia 3
SC - Seychelles 3
SN - Senegal 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BE - Belgio 2
DK - Danimarca 2
JM - Giamaica 2
KR - Corea 2
LK - Sri Lanka 2
LY - Libia 2
NI - Nicaragua 2
PY - Paraguay 2
VE - Venezuela 2
AO - Angola 1
AT - Austria 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
CU - Cuba 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
IR - Iran 1
KG - Kirghizistan 1
KW - Kuwait 1
MM - Myanmar 1
MR - Mauritania 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
TH - Thailandia 1
TJ - Tagikistan 1
UY - Uruguay 1
Totale 5.063
Città #
San Jose 361
Kocaeli 269
San Mateo 229
Ashburn 220
Singapore 184
Dallas 155
Toronto 149
Rome 127
Beijing 104
Santa Clara 103
Houston 93
Lawrence 79
Princeton 79
Wilmington 77
Ho Chi Minh City 65
Chandler 63
Hong Kong 53
Hanoi 45
Frankfurt am Main 38
Fairfield 33
Islamabad 32
Shanghai 32
Chicago 31
Los Angeles 26
Munich 25
Redwood City 23
Guangzhou 22
Woodbridge 22
New York 20
Assago 18
Seattle 18
The Dalles 18
Council Bluffs 17
Netanya 16
São Paulo 15
Shenzhen 14
Amsterdam 12
Columbus 12
Dublin 12
Brooklyn 11
Johannesburg 11
Mexico City 11
Ningbo 11
Orem 11
Chennai 10
Constanta 10
Falls Church 10
Tokyo 10
West Jordan 10
Jiaxing 9
Rio de Janeiro 9
Haiphong 8
Stockholm 8
Wroclaw 8
Biên Hòa 7
Cambridge 7
London 7
Milan 7
Roubaix 7
Belo Horizonte 6
Da Nang 6
Dhaka 6
Helsinki 6
Montreal 6
Mumbai 6
Bexley 5
Boston 5
Bristol 5
Cagliari 5
Guayaquil 5
Moscow 5
Pune 5
Suffern 5
Tashkent 5
Amman 4
Atlanta 4
Baghdad 4
Curitiba 4
Guarulhos 4
Hải Dương 4
Jakarta 4
Kuala Lumpur 4
Manaus 4
Medellín 4
Nairobi 4
Quảng Ngãi 4
Rui'an 4
Salvador 4
Santiago 4
Taipei 4
Trento 4
Wuhan 4
Wuxi 4
Belém 3
Boardman 3
Buffalo 3
Calgary 3
Casablanca 3
Chapadinha 3
Charlotte 3
Totale 3.271
Nome #
Direct and indirect pathways of basal ganglia: a critical reappraisal 231
Motor learning and metaplasticity in striatal neurons: relevance for Parkinson's disease 101
Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism. 92
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuo-spatial memory alteration. 82
Dopamine drives binge-like consumption of a palatable food in experimental parkinsonism. 79
Corticostriatal synaptic plasticity alterations in the R6/1 transgenic mouse model of Huntington's disease 75
Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms 75
A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. 74
Interaction between basal ganglia and limbic circuits in learning and memory processes 73
Alpha-Synuclein Produces Early Behavioral Alterations via Striatal Cholinergic Synaptic Dysfunction by Interacting With GluN2D N-Methyl-D-Aspartate Receptor Subunit 73
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap 71
Striatal spreading depolarization: possible implication in L-DOPA-induced dyskinetic like-behavior. 71
NMDA receptor G1uN2D subunit participates to levodopa-induced dyskinesia pathophysiology 68
Serotonin drives striatal synaptic plasticity in a sex-related manner 68
Theta-burst stimulation and striatal plasticity in experimental parkinsonism 66
Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias 65
Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment 65
l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation. 64
Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia 64
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease 64
The Distinct Role of Medium Spiny Neurons and Cholinergic Interneurons in the D-2/A(2A) Receptor Interaction in the Striatum: Implications for Parkinson's Disease 64
A positive allosteric modulator of mGlu4 receptors restores striatal plasticity in an animal model of L-Dopa-induced dyskinesia 63
Prenatal stress and hippocampal BDNF expression: a fading imperative 63
Transcranial Magnetic Stimulation Exerts "Rejuvenation" Effects on Corticostriatal Synapses after Partial Dopamine Depletion 63
Intensive exercise ameliorates motor and cognitive symptoms in experimental Parkinson's disease restoring striatal synaptic plasticity 63
Striatum-hippocampus balance: From physiological behavior to interneuronal pathology 62
Reply to: Rewiring Brains in Parkinson's Disease: The New Era of Brain Stimulation 61
Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome. 61
Memantine alters striatal plasticity inducing a shift of synaptic responses toward long-term depression 60
Effects of uremic toxins on hippocampal synaptic transmission: implication for neurodegeneration in chronic kidney disease 60
Derangement of Ras-Guanine Nucleotide-Releasing Factor 1 (Ras-GRF1) and Extracellular Signal-Regulated Kinase (ERK) Dependent Striatal Plasticity in L-DOPA-Induced Dyskinesia 59
L-DOPA reverses the impairment of Dentate Gyrus LTD in experimental parkinsonism via beta-adrenergic receptors 59
Environmental enrichment restores CA1 hippocampal LTP and reduces severity of seizures in epileptic mice 58
Neural networks and synaptic plasticity in Parkinson's disease: beyond motor deficits 58
Alpha-synuclein and cortico-striatal plasticity in animal models of Parkinson disease 57
Hyperkinetic disorders and loss of synaptic downscaling 57
FUNCTIONAL INTERACTIONS WITHIN STRIATAL MICROCIRCUIT IN ANIMAL MODELS OF HUNTINGTON'S DISEASE 56
Dopamine-Dependent Long-Term Depression Is Expressed in Striatal Spiny Neurons of Both Direct and Indirect Pathways: Implications for Parkinson's Disease 56
Dopamine-dependent early synaptic and motor dysfunctions induced by a-synuclein in the nigrostriatal circuit 55
Levodopa-induced plasticity: a double-edged sword in Parkinson's disease? 55
Epilepsy-induced abnormal striatal plasticity in Bassoon mutant mice. 55
Environmental Enrichment and Functional Plasticity in the Hippocampus – An Update on the Mechanisms Involved 55
Molecular mechanisms underlying levodopa-induced dyskinesia. 54
mTOR inhibitor rapamycin suppresses striatal post-ischemic LTP 54
Plastic abnormalities in experimental Huntington's disease 53
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 52
Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition 52
Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia 52
"Lazy" nigrostriatal synapses in the heterozygous PINK1 mouse model of familial Parkinson's disease 51
L-3,4-Dihydroxyphenylalanine-Induced Sprouting of Serotonin Axon Terminals: A Useful Biomarker for Dyskinesias? 51
Rebalance of Striatal NMDA/AMPA Receptor Ratio Underlies the Reduced Emergence of Dyskinesia During D2-Like Dopamine Agonist Treatment in Experimental Parkinson's Disease 51
The endocannabinoid system in Parkinson's disease. 51
Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction 50
Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons 50
Assemblies of glutamate receptor subunits with post-synaptic density proteins and their alterations in Parkinson's disease 49
Sarcopenia and Cognitive Decline in Older Adults: Targeting the Muscle-Brain Axis 49
Long-Term Shaping of Corticostriatal Synaptic Activity by Acute Fasting 49
Attachment and parental reflective functioning features in ADHD: Enhancing the knowledge on parenting characteristics 48
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease 48
Striatal synaptic changes in experimental parkinsonism: role of NMDA receptor trafficking in PSD. 48
Rhes influences striatal cAMP/PKA-dependent signaling and synaptic plasticity in a gender-sensitive fashion 48
Intermittent Theta-burst Stimulation Rescues Dopamine-Dependent Corticostriatal Synaptic Plasticity and Motor Behavior in Experimental Parkinsonism: Possible Role of Glial Activity 48
CalDAG-GEFI mediates striatal cholinergic modulation of dendritic excitability, synaptic plasticity and psychomotor behaviors 48
Astrocyte Responses Influence Local Effects of Whole‐Brain Magnetic Stimulation in Parkinsonian Rats 47
Cigarette smoke inhalation stimulates dopaminergic neurons in rats 46
Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons 45
Striatal glutamatergic hyperactivity in Parkinson's disease 44
Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease 44
Short-term and long-term plasticity at corticostriatal synapses: implications for learning and memory 44
Direct and indirect pathways in levodopa-induced dyskinesia: a more complex matter than a network imbalance. 44
Impairment of long term depression in dyskinetic rats: A critical role of NO/cGMP pathway in recovering synaptic plasticity 44
Effects of safinamide on the glutamatergic striatal network in experimental Parkinson's disease 43
Interferon-β1a protects neurons against mitochondrial toxicity via modulation of STAT1 signaling: electrophysiological evidence 42
Neuronal networks and synaptic plasticity in Parkinson's disease: beyond motor deficits 42
Alpha-synuclein: From early synaptic dysfunction to neurodegeneration 39
Advances in understanding the function of alpha-synuclein: implications for Parkinson’s disease 39
Rapamycin, by Inhibiting mTORC1 Signaling, Prevents the Loss of Striatal Bidirectional Synaptic Plasticity in a Rat Model of L-DOPA-Induced Dyskinesia 39
Molecular and cellular determinants of L-Dopa-induced dyskinesia in Parkinson’s Disease 38
Neurofunctional effects of developmental alcohol exposure in alcohol-preferring and alcohol-nonpreferring rats 37
Le emozioni nei contesti individuali e sociali 37
Synaptic dysfunction in Parkinson's disease 36
Reply to: Rewiring Brains in Parkinson's Disease: The New Era of Brain Stimulation 35
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 35
Environmental enrichment repairs structural and functional plasticity in the hippocampus 33
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease 32
Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release 31
Neuro-Immune Cross-Talk in the Striatum: From Basal Ganglia Physiology to Circuit Dysfunction 30
Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat 30
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 30
Rhes, a key element of selective neuronal vulnerability in Huntington's disease: a striatal-specific license to kill during energy metabolism failure 29
Repetitive transcranial magnetic stimulation reduces remote apoptotic cell death and inflammation after focal brain injury 28
Hippocampal enlargement in Bassoon-mutant mice is associated with enhanced neurogenesis, reduced apoptosis, and abnormal BDNF levels 27
Maternal stress programs accelerated aging of the basal ganglia motor system in offspring 27
TrkB/BDNF-dependent striatal plasticity and behavior in a genetic model of epilepsy: modulation by valproic acid 25
Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit 24
Backtracking α-synuclein pathology: social deficits precede motor symptoms in Parkinson’s disease 22
Synaptic Interactions Between Serotonergic and Dopaminergic Systems in Parkinson’s Disease 21
Totale 5.186
Categoria #
all - tutte 46.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.741


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021290 0 0 0 0 0 0 0 0 0 0 269 21
2021/2022507 10 141 143 0 3 7 18 50 27 92 9 7
2022/2023336 178 2 3 20 30 6 4 8 15 21 40 9
2023/2024252 0 2 11 60 8 7 1 3 8 25 20 107
2024/2025868 36 205 46 21 40 148 26 76 102 13 42 113
2025/20262.427 203 190 223 221 163 251 359 178 213 368 58 0
Totale 5.186